The tenth annual conference on Alzheimer's disease continues in Madrid and one of the most surprising, but promising treatments presented so far was not discovered by a scientist. Years ago, the discoverer noticed her husband's Alzheimer's started improving when he began taking hormone therapy to treat his prostate cancer.
"That was the initial finding about ten years ago now. And so since then we've done a lot of work to look at how that particular hormone drug affects the different pathologies and risk factors for Alzheimer's," said Chris Gregory, PhD, Voyager Pharmaceuticals.
Today the prostate cancer drug Leuprolide Acetate is entering phase three trials as therapy for mild to moderate cases of Alzheimer's. Scientists are trying to figure out how and why the hormone therapy has some effect on the brain.